Investor concerns over the renewable energy sector's near-term prospects were evident on Friday, with Adani Green Energy ...

Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower. Find out why?

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...

Brokerages were especially impressed by ICICI Bank's strong CASA growth in Q3 that bucked the industry trend of a decline. In ...

Nuvama Wealth Management announced the date to declare its third-quarter FY2024-25 results on Friday, January 24. Shares were ...

NTPC's net profit for the three months ended December 2024 saw a 3.1 percent increase on-year, rising to Rs 4,711.4 crore.

Lower credit costs led by better recoveries resulted in best return ratios in the last few years for ICICI Bank with an RoA ...

The company's net profit is expected to range between Rs 9,137 crore and Rs 7,660 crore. Nuvamas PAT figures are adjusted, ...

Nuvama is Cautious in ITC. This is because of continued concerns in the FMCG segment and the market anticipating a potential ...

The fund focuses on Grade A+ office spaces across key micro-markets in India's six largest cities: Bengaluru, the National ...

MOFSL said NTPC's standalone Q3 Ebitda came in 2 per cent above its estimates, though adjusted PAT was below due to a ...

Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings ...